Ceramides and Skin Health: New Insights
- PMID: 39912256
- DOI: 10.1111/exd.70042
Ceramides and Skin Health: New Insights
Abstract
Ceramide has transitioned from an incidental discovery to a vital element in skincare, becoming a thoroughly studied compound in the quest to treat skin conditions. Creating a moisture barrier, preserving hydration, regulating pH, controlling inflammation, and enhancing skin functions and appearance are among its established benefits. It is often used medically to repair skin barrier defects, as observed in inflammatory skin conditions like atopic dermatitis (AD) and dry skin types. Furthermore, ceramide and its metabolites are commonly used as predictors before disease manifestation and for prognostication processes, thus can be used as biomarker for clinical diagnosis as well. In the last couple of decades, momentum was also seen in the pre-clinical studies involving anti-cancer and nanotechnology field, whereby ceramide was also used as a drug, a carrier, or even adjunct formulation to increase efficacy of treatment such as chemotherapy. Approaches to increase ceramide levels include directly replenishing lost ceramides with natural extracts, synthetic pseudo-ceramides, or ceramide-like analogues, as well as using supplements that stimulate the body's natural ceramide production. Although ceramide is a well-known treatment in skincare and for common skin conditions like AD and psoriasis, its development and related pharmacology for severe skin conditions, such as skin cancer, remain in pre-clinical stages. Hence, the purpose of this research is to explore the role of ceramide in skin health and its application in common skin diseases.
Keywords: anti‐inflammatory; ceramide; skin barrier function; skin disease; skin hydration.
© 2025 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
-
- E. Harazim, V. Vrkoslav, M. Budesinsky, et al., “Nonhydroxylated 1‐O‐Acylceramides in Vernix Caseosa,” Journal of Lipid Research 59, no. 11 (2018): 2164–2173, https://doi.org/10.1194/jlr.M088864.
-
- K. K. A. Vávrová and L. Opálka, “Ceramides in the Skin Barrier,” European Journal of Pharmaceutical Sciences 64, no. 1 (2017): 1–8, https://doi.org/10.1515/afpuc‐2017‐0004.
-
- F. Afrin, S. Mateen, J. Oman, J. C. K. Lai, J. J. Barrott, and S. Pashikanti, “Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells,” Cancers (Basel) 15, no. 18 (2023): 4645, https://doi.org/10.3390/cancers15184645.
-
- R. L. Giesey, S. Mehrmal, P. Uppal, and G. R. Delost, “Global Burden of Skin and Subcutaneous Disease: A Longitudinal Analysis From the Global Burden of Disease Study From 1990–2017,” SKIN The Journal of Cutaneous Medicine 5, no. 2 (2021): 125–136, https://doi.org/10.25251/skin.5.2.7.
-
- C. E. Griffiths, P. van de Kerkhof, and M. Czarnecka‐Operacz, “Psoriasis and Atopic Dermatitis,” Dermatologic Therapy 7, no. Suppl 1 (2017): 31–41, https://doi.org/10.1007/s13555‐016‐0167‐9.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical